The Efficacy and Safety of Gliquidone in Thai Diabetics

Journal of the Medical Association of Thailand

Volumn 80, Issue 12, 1997, Pages 771-776

  Nitiyanant, Wannee ^a   Sriussadaporn, Sutin ^a   Deerochanawong, Chaicharn ^b   Ngawngamrat, Supannee ^b   Benjasuratwong, Yupin ^c   Patanaungkul, Somchai ^c  

^a MAHIDOL UNIVERSITY   (Thailand)

^b RAJAVITHI HOSPITAL   (Thailand)

^c Pramongkutklao General Hospital   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; GLIQUIDONE; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BLOOD CELL COUNT; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL DRUG ADMINISTRATION; THAILAND; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; CHOLESTEROL; CHOLESTEROL, LDL; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MIDDLE AGED; SULFONYLUREA COMPOUNDS; THAILAND;

EID: 0031451660     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Report of the National Working Group for Control of Diabetes Mellitus. Diabetes Mellitus in Thailand 1987. Ministry of Health, Bangkok, 1988: 14-32.
2. Nitiyanant W, Vannasaeng S, Vichayanrat A, Sriussadapom S, Piraphatdist T, Komoltri C. Management of diabetes mellitus in Siriraj diabetic clinic. Intern Med 1991; 7: 46-50.
3. Thai Multicenter Research Group on Diabetes Mellitus. Vascular complications in non-insulin dependent diabetics in Thailand. Diabetes Res Clin Pract 1994; 25: 61-9.
4. Verspohl EJ, Ammon HPT, Mark M. Evidence for more than one binding site for sulfonylureas in insulin-secreting cells. J Pharm Pharmacol 1990; 42: 230-5.
5. Ferner RE, Chaplin S. The relationship between the pharmacokinetics and pharmacodynamic effects of oral hypoglycemic drugs. Clinical Pharmacokinetics 1987; 12: 379-401.
6. Groop LC. Sulfonylureas in NIDDM. Diabetes Care 1992; 15: 737-54.
7. Mooradian AD. Drug therapy of non-insulin-dependent diabetes mellitus in the elderly. Drug 1996; 51: 931-41.
8. Matyka K, Cranston I, Evans M, MacDonald I, Lomas J, Amiel SA. Altered hierarchy of protective responses against severe hypoglycemia in normal aging in healthy men. Diabetes Care 1997; 20: 135-41.
9. Melander A, Lebovitz HE, Faber OK. Sulfonylureas : why, which and how? Diabetes Care 1990; 13 (Suppl. 3): 18-25.
10. Limmer L, Konig E, Rupprecht E, Profozic V, Granic M, Skrabalo Z. The efficacy and tolerance of glurenorm. Results of a multicenter long-term trial for period of 18 and 30 months. Diabetologia Croatica 1992; 20 (Suppl. 1): 3-20.
11. Report of the WHO Study Group. Diabetes Mellitus. WHO Technical Report Series 727. WHO, Geneva 1985: 9-25.
12. Vichayanrat A, Ploybutr S, Nitiyanant W, Vannasaeng S. Comparision between colorimetric and column chromatografic methods for the determination of glycosylated hemoglobin. J Med Assoc Thai 1984; 67: 278-82.
13. Alberti KGMM, Gries FA. Management of non-insulin-dependent diabetes mellitus in Europe; a consensus view. Diabetic Med 1988; 5: 275-81.
14. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifugation. Clin Chem 1972; 18: 499-502.
15. Galeone F, Saba P, Saponati G. Gliquidone (Glurenor) in long-term treatment of type II diabetes mellitus. Clinical Trials J 1989; 26: 108-18.
16. Borthwick LJ, Wilson S. Diabetic control with gliquidone - a short acting sulphonylurea. Clin Pharmacol 1984; 26: 475-9.
17. American Diabetes Association. Position Statement. Standards of medical care for patients with diabetes mellitus. Diabetes Care 1997;20(Suppl 1): S5-S13.
18. Harrower ADB. Comparision of diabetic control in type 2 (non-insulin dependent) diabetic patient treated with different sulphonylureas Curr Med Res Opin 1985; 9: 676-80.
19. Bonora E, Moghetti P, Querena M, et al. Studies on the mechanism of action of sulphonylureas in type II diabetic subjects : gliquidone. J Endocrinol Invest 1992; 15: 1-11.
20. Taskinen MR, Bogardus C, Kennedy A, Howard BV. Multiple disturbances of free fatty acid metabolism in noninsulin- dependent diabetes. Effect of oral hypoglycemic therapy. J Clin Invest 1985; 76: 637-44.
21. Howard BV. Pathogenesis of diabetic dyshpidemia. Diabetes Reviews 1995; 3: 423-32.
22. U.K. Prospective Diabetes Study Group. Prospectives in diabetes. U.K. Prospective Diabetes Study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. Diabetes 1995; 44: 1249-58.
23. Cerasi E, Efendic S, Thomqvist C, Luft R. Effect of two sulphonylureas on the dose kinetics of glucose-induced insulin release in normal and diabetic subjects. Acta Endocrinol 1979; 91: 282-93.